215 related articles for article (PubMed ID: 1725631)
1. [Hepatitis C virus antibodies (anti-HCV) prevalence rate in anti-HBc-negative blood donors].
Baur P; Roelcke D
Beitr Infusionsther; 1991; 28():25-6. PubMed ID: 1725631
[TBL] [Abstract][Full Text] [Related]
2. [HCV antibodies in selected patient groups and blood donors].
Courault K; Lisse C; Ehrenberg M; Stolle K; Brandstädter W; Fritzsche L
Beitr Infusionsther; 1991; 28():22-4. PubMed ID: 1725624
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C virus (HCV) antibodies in German blood donors--a pilot study].
Seidl S; Kühnl P; Beyer J; Stangel W; Flik J; Sibrowski W; Roos D; Bornhövd K; Kalmar G; Flacke H
Beitr Infusionsther; 1990; 26():18-21. PubMed ID: 2177676
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of antibodies to hepatitis C virus in relation to surrogate markers in a blood donor population of Singapore.
Kuperan P; Choon AT; Ding SH; Lee G
Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():127-9. PubMed ID: 7533946
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of hepatitis B virus markers for surrogate testing of hepatitis C].
Ohto H; Nomura H; Ohmura K; Ishijima A; Okazaki S
Rinsho Byori; 1991 Jan; 39(1):14-7. PubMed ID: 1848910
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of HBsAg, anti-HBc and anti-HCV in blood donor candidates at the Campinas hemocenter].
Gonçales Júnior FL; Boccato RS; Pedro Rde J; Papaiordanou PM; de Souza CA; Gonçales NS; Pellegrino Júnior J
Rev Inst Med Trop Sao Paulo; 1993; 35(1):45-51. PubMed ID: 7506445
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of hepatitis C virus antibodies in hospital personnel and the general population].
Abb J
Offentl Gesundheitswes; 1991 Apr; 53(4):158-60. PubMed ID: 1714067
[TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies to hepatitis C virus in blood donors and their relationship to surrogate markers.
Hugo T; Wüst T; Beeser HP
Beitr Infusionsther; 1992; 30():49-52. PubMed ID: 1284765
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of seromarkers of HBV and HCV among blood donors in eastern Saudi Arabia, 1998-2001.
Bashawri LA; Fawaz NA; Ahmad MS; Qadi AA; Almawi WY
Clin Lab Haematol; 2004 Jun; 26(3):225-8. PubMed ID: 15163322
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction.
Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS
Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269
[TBL] [Abstract][Full Text] [Related]
11. [Screening of Danish blood donors for hepatitis C virus antibodies].
Wantzin PS; Krogsgaard K; Dickmeiss E
Ugeskr Laeger; 1990 Sep; 152(39):2846-8. PubMed ID: 2120833
[TBL] [Abstract][Full Text] [Related]
12. Estimated risk of transmission of hepatitis C virus by blood transfusion.
Koerner K; Cardoso M; Dengler T; Kerowgan M; Kubanek B
Vox Sang; 1998; 74(4):213-6. PubMed ID: 9691400
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of hepatitis B and hepatitis C virus infections in potential blood donors in rural Cambodia.
Ol HS; Bjoerkvoll B; Sothy S; Van Heng Y; Hoel H; Husebekk A; Gutteberg T; Larsen S; Husum H
Southeast Asian J Trop Med Public Health; 2009 Sep; 40(5):963-71. PubMed ID: 19842380
[TBL] [Abstract][Full Text] [Related]
14. [The prevalence of hepatitis C antibodies among volunteer blood donors with elevated blood transaminase and antibodies to the B virus core antigen].
Gavilán Carrasco JC; González Santos P; Rosario Díaz E
Rev Clin Esp; 1996 May; 196(5):277-80. PubMed ID: 8768025
[TBL] [Abstract][Full Text] [Related]
15. [Hepatitis C virus antibodies in patients following blood transfusion and kidney transplantation].
Baur P; Daniel V; Pomer S; Scheurlen H; Opelz G; Roelcke D
Beitr Infusionsther; 1991; 28():27-8. PubMed ID: 1725637
[TBL] [Abstract][Full Text] [Related]
16. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
17. Significance of isolated hepatitis B core antibody in blood donors.
Schifman RB; Rivers SL; Sampliner RE; Krammes JE
Arch Intern Med; 1993 Oct; 153(19):2261-6. PubMed ID: 8215729
[TBL] [Abstract][Full Text] [Related]
18. Missed opportunities: ALT and anti-HBc as surrogate tests for hepatitis.
Bettigole R; Shastri KA
J Med; 1997; 28(5-6):363-9. PubMed ID: 9604794
[TBL] [Abstract][Full Text] [Related]
19. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
[TBL] [Abstract][Full Text] [Related]
20. [Anti-hepatitis C prevalence and incidence in 2.8 million blood donors in Lower Saxony--residual transfusion-associated HCV risk].
Diekamp U; Kamutzky K; Windel CD
Beitr Infusionsther Transfusionsmed; 1997; 34():5-10. PubMed ID: 9417352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
